ElectroKare

Setting the Scene

  • Electrolyte imbalances during physical activity can hinder performance and lead to dangerous health outcomes, yet most athletes lack real-time insights to manage this effectively.

  • Problems with today’s tracking:

    • Inefficiency: Current solutions either require invasive methods or rely on guesswork, leading to poor training outcomes and recovery.

    • Danger: Poorly monitored electrolyte depletion can cause symptoms ranging from cramps to seizures, putting athletes at risk.

  • This week’s company offers an electrolyte tracking technology to provide actionable insights.

In a Sentence

ElectroKare is an AI-powered, non-invasive electrolyte tracking software, offering athletes insights into their electrolyte levels during workouts.

  • Non-invasive: An electrocardiogram (EKG) is taken from a smartwatch, chest strap, or similar device, to receive results instantly.

  • Tracking: ElectroKare offers actionable insights into electrolyte levels, helping the body determine its specific needs for effective recovery.

logo image

Bulleted Version:

  • Think of ElectroKare like the Fitbit for your electrolyte levels. Just as Fitbit tracks your steps, ElectroKare tracks your electrolytes using the data from your smartwatch’s EKG sensors.

The Basics

  • Headquarters: Vernon Hills, IL
  • Employee Count: 2
  • Investors:

    Techstars and iVenture

  • Funding amount: $140k
  • Business model: B2C subscription model and B2B with customers like sports teams and hospitals
  • Early traction: 7 signed teams ($177k in ARR), 2300+ waitlist for the pilot launch, non-invasive electrolyte tracking via smartwatch ECG at ~70% accuracy

Due Diligence

WHAT WE LIKE

  • Market Opportunity: The projected global end-user spending on wearable devices in 2022 was estimated to be around $81.5 billion.

  • Performance Optimization: With a growing focus on recovery as a key factor in performance, ElectroKare meets the needs of 4.4 million competitive athletes in the U.S. seeking every advantage in training and recovery.

  • Beyond Athletics: ElectroKare’s technology has long-term potential beyond sports, with hospitals being a key target for non-invasive electrolyte monitoring in patient care.

POTENTIAL RISKS

  • Accuracy: With a current 70% accuracy rate, further improvements are necessary to build trust with high-performance athletes and healthcare providers.

  • Consumer Awareness: Many individuals may not fully understand the importance of electrolyte tracking, which could limit initial demand without proper education.

  • Privacy Concerns: As with any health-tracking technology, concerns around data privacy could hinder adoption unless robust security measures are clearly communicated.

cartoon

Founder Profile

  • Mitchell Leshchiner, CEO: Previously bootstrapped previous startup to 6 figures in ARR for 2-3 years, played professional soccer in France.

  • Josh Malinkovish, CTO: Previously worked as CTO on various Venture-backed startups, background in Bioengineering and Computer Science.

Comps

Why ElectroKare

  • By developing a non-invasive, automated method to track electrolyte levels affordably, accurately, and across platforms, ElectroKare enables individuals to take better care of their bodies.

*Nothing in this content constitutes investment or legal advice. The information provided should not be used as the basis for making investment decisions. Readers should conduct their own research and consult with investment advisers before making investment decisions.*